Maria Livia Del Giudice

11PUBLICATIONS
41CO-AUTHORS
Haematological tumoursMedical mycologyMedical biotechnology diagnostics (incl. biosensors)AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 18, 2026
Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

|Jun 26, 2026
Early Soluble B-Cell Maturation Antigen (BCMA/TNFRSF17) Kinetics as a Molecular Biomarker of Treatment Response in Multiple Myeloma Patients.

|Feb 26, 2025
Monoclonal Antibodies in Relapsed-Refractory Multiple Myeloma.

Ilaria Sorgiovanni, Maria Livia Del Giudice, Sara Galimberti

|Jan 16, 2025
Predictive Role of Soluble B-Cell Maturation Antigen in Short-Term Monitoring of Differently Treated Multiple Myeloma Patients: A Prospective Study.

Laura Caponi, Maria Livia Del Giudice, Alice Botti

|Jul 18, 2024
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis.

Raffaella Cassano Cassano, Dario Genovesi, Giuseppe Vergaro

|Apr 09, 2024
Novel monoclonal antibodies: A really specific therapy for light chain amyloidosis.

Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda

Pageof 2

Frequent Collaborators

2 joint publications

Massimo Offidani

2 joint publications

Alessandro Gozzetti

2 joint publications

Monica Bocchia

2 joint publications

Sara Galimberti